New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
11:17 EDTLNKD, ETRM, ONCY, TRP, NUANHigh option volume stocks; ETRM NUAN ONCY LNKD TRP
News For ETRM;NUAN;ONCY;LNKD;TRP From The Last 14 Days
Check below for free stories on ETRM;NUAN;ONCY;LNKD;TRP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 14, 2014
06:33 EDTONCYOncolytics Biotech collaborators present head, neck cancer biomarker poster
Subscribe for More Information
April 11, 2014
08:00 EDTLNKDLinkedIn remains a favorite large cap name at Piper Jaffray
Piper Jaffray says LinkedIn remains one of its favorite long-term large cap names. The firm believes investors are overlooking two new opportunities for the company: the addition of Sales Solutions and the Ad API. Piper reiterates an Overweight rating on LinkedIn with a $270 price target.
06:47 EDTLNKDSamsung ups S5 incentives to fend off rivals, Bloomberg says
Subscribe for More Information
April 10, 2014
10:44 EDTLNKDStocks with call strike movement; FSLR LNKD
Subscribe for More Information
April 9, 2014
10:06 EDTLNKDOn The Fly: Analyst Upgrade Summary
AmSurg (AMSG) upgraded to Buy from Hold at Cantor... CBOE Holdings (CBOE) upgraded to Buy from Neutral at BofA/Merrill... Carlyle Group (CG) upgraded to Outperform from Perform at Oppenheimer... FireEye (FEYE) upgraded to Buy from Hold at Topeka... Fortune Brands (FBHS) upgraded to Outperform from Neutral at Credit Suisse... Gray Television (GTN) upgraded to Outperform from Market Perform at Wells Fargo... Hibbett Sports (HIBB) upgraded to Overweight from Neutral at Piper Jaffray... LinkedIn (LNKD) upgraded to Buy from Hold at Topeka... Mallinckrodt (MNK) upgraded to Buy from Neutral at UBS... NXP Semiconductors (NXPI) upgraded to Strong Buy from Outperform at Raymond James... Nexstar (NXST) upgraded to Outperform from Market Perform at Wells Fargo... Penn National (PENN) upgraded to Overweight from Equalweight at Barclays... Philip Morris (PM) upgraded to Neutral from Reduce at Nomura... SAIC (SAIC) upgraded to Market Perform from Underperform at Wells Fargo... Sinclair Broadcast (SBGI) upgraded to Outperform from Market Perform at Wells Fargo... Yelp (YELP) upgraded to Buy from Fair Value at CRT Capital... Danaher (DHR) upgraded to Strong Buy from Buy at ISI Group... Quanex (NX) upgraded at BB&T... Omnicell (OMCL) upgraded at Craig-Hallum... Volkswagen (VLKAY) upgraded to Outperform from Market Perform at Bernstein... Magna (MGA) upgraded to Neutral from Sell at Citigroup... Actavis (ACT) upgraded to Positive from Neutral at Susquehanna... E-Trade (ETFC) upgraded to Neutral from Underperform at BofA/Merrill... AmerisourceBergen (ABC) upgraded to Outperform from Market Perform at FBR Capital... CONSOL (CNX) upgraded to Outperform from Neutral at Macquarie.
09:36 EDTLNKDActive equity options trading on open
Subscribe for More Information
09:11 EDTLNKDOn The Fly: Pre-market Movers
Subscribe for More Information
06:33 EDTLNKDLinkedIn upgraded to Buy from Hold at Topeka
Subscribe for More Information
April 8, 2014
16:21 EDTLNKDOn The Fly: Closing Wrap
Subscribe for More Information
09:00 EDTONCYOncolytics Biotech rises 12.4%
Subscribe for More Information
06:38 EDTONCYOncolytics Biotech reports tumor stabilization or shrinkage in REOLYSIN study
Oncolytics Biotech announced additional data from the Company's randomized, double-blinded clinical study examining REOLYSIN in combination with carboplatin and paclitaxel in patients with second-line, platinum-refractory, taxane-na´ve head and neck cancers, or REO 018. Highlights include: 118 patients had loco-regional head and neck disease, with or without distal metastases An intent-to-treat analysis of the overall survival, or OS, of the 118 patients with loco-regional disease was performed on all patients to the median PFS in each arm, censoring any patients who received post-discontinuation therapy at the date at which they commenced the first of these therapies. This analysis demonstrated a statistically significant improvement in OS for the test arm versus the control arm; and the 118 patients with loco-regional head and neck disease, with or without distal metastases, were evaluated for percentage magnitude of tumour shrinkage at the first post-treatment scan. The test arm showed a statistical trend towards better tumour stabilization or shrinkage over the control arm. There were 47 patients with distal metastases alone. At the time of the analysis, eight of the 47 patients were still alive. The test arm patients in this group maintained a PFS benefit over control arm patients for five cycles of therapy. There are too few patients to power a statistical analysis of the PFS and OS of this patient group; and the 47 patients with distal metastases alone were evaluated for percentage magnitude of tumour shrinkage at the first post-treatment scan (performed at approximately six weeks). The test arm demonstrated statistically significantly better tumour stabilization or shrinkage than the control arm.
06:37 EDTONCYOncolytics Biotech to host conference call
Conference call to discuss additional data analysis from the Company's REO 018 trial in head and neck cancers will be held on April 8 at 7:45 am. Webcast Link
06:35 EDTONCYOncolytics Biotech announces additional data from REO 018 study of Reolysin
Subscribe for More Information
April 7, 2014
15:16 EDTLNKDLinkedin May volatility elevated as shares trend to 13-month low
Subscribe for More Information
April 4, 2014
12:17 EDTLNKDLinkedin May volatility elevated as shares trend to nine-month low
Linkedin April call option implied volatility is at 44, May is at 56, June and August is at 45; compared to its 26-week average of 43 according to Track Data, suggesting large May price movement.
10:03 EDTLNKDLinkedIn continues lower, levels to watch
Subscribe for More Information
07:16 EDTNUANNuance shares should be bought on any weakness, says Oppenheimer
Subscribe for More Information
April 3, 2014
09:37 EDTLNKDActive equity options trading on open
Subscribe for More Information
08:02 EDTTRPCanadian Association of Petro Producers & Scotiabank co-host a symposium
Subscribe for More Information
07:55 EDTNUANNuance seems to be powering Amazon Fire TV voice search, says Wedbush
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use